Herforth Christine, Zimmern Philippe E
Department of Urology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
Case Rep Womens Health. 2024 Sep 5;43:e00649. doi: 10.1016/j.crwh.2024.e00649. eCollection 2024 Oct.
Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management.
Macroplastique®是一种用于治疗女性压力性尿失禁的尿道周围填充剂。它由悬浮于聚乙烯吡咯烷酮载体中的聚二甲基硅氧烷大颗粒组成,以便于注射。本病例报告中的患者在先前注射Macroplastique®的部位,PET扫描显示18F-FDG摄取增加。这种摄取可能是由于局部炎症反应,并不代表隐匿性恶性肿瘤。对于先前接受过填充治疗的女性,当出现这种PET摄取增加区域时,需要敏锐的临床判断,因为这是一个偶然的良性发现,不需要进一步的侵入性处理。